the effects of short-term ( 6 months ) , low-dose ( 5 mg/kg body mass/d ) etidronate disodium , a diphosphonate compound at present subject to registration in this country , on the clinical and laboratory manifestations of this disorder were examined .
C0086268
etidronate
C0012544
diphosphonate